Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alere Inc (NYSE:ALR)

39.13
Delayed Data
As of Mar 24
 +1.24 / +3.27%
Today’s Change
31.47
Today|||52-Week Range
51.00
+0.41%
Year-to-Date
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
Stonepine Capital Management, LLC Buys Recro Pharma, SciClone Pharmaceuticals, Noveli...
Mar 21 / GuruFocus News - Paid Partner Content
Can Abbott Outperform Despite Alere?
Mar 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close37.89
Today’s open38.02
Day’s range37.85 - 39.22
Volume1,380,619
Average volume (3 months)629,576
Market cap$3.4B
Dividend yield--
Data as of 4:02pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-212.07%
Earnings growth (this year)-47.55%
Earnings growth (next 5 years)+6.70%
Revenue growth (last year)-4.77%
P/E ratioNM
Price/Sales1.36
Price/Book2.33

Competitors

 Today’s
change
Today’s
% change
NEOGNeogen Corp-0.30-0.47%
AAAPAdvanced Accelerator...-0.60-1.52%
MYGNMyriad Genetics Inc+0.23+1.20%
IMMUImmunomedics Inc+0.25+3.77%
Data as of 4:14pm ET, 03/24/2017

Financials

Last reporting dateMarch 27, 2017
EPS forecast (this quarter)$0.52
Annual revenue (last year)$2.5B
Annual profit (last year)-$16.0M
Net profit margin-0.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Namal Nawana
Senior Vice President-
Global Operations
Mark Gladwell
Corporate headquarters
Waltham, Massachusetts

Forecasts


Search for Jobs